Terms: = Lymphoma AND IL2, IL-2, 3558, ENSG00000109471, P60568
1849 results:
1. Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1.
Tran TM; Chand Thakuri BK; Nurmukhambetova S; Lee JJ; Hu P; Tran NQ; Steimle B; Dash P; Schneider D
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38609317
[TBL] [Abstract] [Full Text] [Related]
2. A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting
Kumaresan PR; Wurster S; Bavisi K; da Silva TA; Hauser P; Kinnitt J; Albert ND; Bharadwaj U; Neelapu S; Kontoyiannis DP
mBio; 2024 Apr; 15(4):e0341323. PubMed ID: 38415653
[TBL] [Abstract] [Full Text] [Related]
3. Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-il2 bispecific immunotoxin in rats and minipigs.
Wang Z; Ramakrishna R; Wang Y; Qiu Y; Ma J; Mintzlaff D; Zhang H; Li B; Hammell B; Lucia MS; Pomfret E; Su AA; Washington KM; Mathes DW; Wang Z
Eur J Pharmacol; 2024 Apr; 968():176408. PubMed ID: 38367684
[TBL] [Abstract] [Full Text] [Related]
4. Molecular mechanism of selenium against lead-induced apoptosis in chicken brainstem relating to heat shock protein, selenoproteins, and inflammatory cytokines.
Chen D; Yu W; Hao Z; Qiu M; Cui J; Tang Y; Teng X; Liu Y; Liu H
Ecotoxicol Environ Saf; 2024 Mar; 272():116028. PubMed ID: 38310824
[TBL] [Abstract] [Full Text] [Related]
5. Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-lymphoma.
Nakashima M; Tanaka Y; Okamura H; Kato T; Imaizumi Y; Nagai K; Miyazaki Y; Murota H
Cells; 2024 Jan; 13(2):. PubMed ID: 38247820
[TBL] [Abstract] [Full Text] [Related]
6. Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system.
Jedlowski PM; DuPont JP
J Eur Acad Dermatol Venereol; 2024 May; 38(5):937-944. PubMed ID: 38071595
[TBL] [Abstract] [Full Text] [Related]
7. Longitudinal dynamics of gut microbiota in the pathogenesis of acute graft-versus-host disease.
Qi L; Peng J; Huang X; Zhou T; Tan G; Li F
Cancer Med; 2023 Dec; 12(24):21567-21578. PubMed ID: 38053512
[TBL] [Abstract] [Full Text] [Related]
8. Higher Expression of Human Endogenous Retrovirus-K was Observed in Peripheral B Lymphocytes of Leukemia and lymphoma Patients.
Li T; Qian K; Han J; Liu Y; Jia L; Wang X; Li T; Zhang B; Li J; Li H; Dou L; Li L
AIDS Res Hum Retroviruses; 2024 Apr; 40(4):268-279. PubMed ID: 38009220
[TBL] [Abstract] [Full Text] [Related]
9. Predictive factors and scoring system for intravascular large B-cell lymphoma among suspected cases: a single-center retrospective analysis.
Tanaka M; Miyagaki T; Okano T; Takeuchi S; Kadono T
Int J Dermatol; 2024 Jan; 63(1):79-84. PubMed ID: 37955167
[TBL] [Abstract] [Full Text] [Related]
10. Adverse events and efficacy of second-round CAR-T cell therapy in relapsed pediatric B-ALL.
Ji Q; Wu X; Zhang Y; Zeng L; Dong Y; Liu R; Li B; Bai Z; Hu S; Lu J; Wu S
Eur J Haematol; 2024 Jan; 112(1):75-82. PubMed ID: 37649264
[TBL] [Abstract] [Full Text] [Related]
11. [Expression and Prognostic Value of Cytokines in Patients with Newly Diagnosed Diffuse Large B-Cell lymphoma].
Man Y; Ge CQ; Li ZZ; Yang TH; Wang YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1050-1055. PubMed ID: 37551476
[TBL] [Abstract] [Full Text] [Related]
12. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes.
Bao C; Gu J; Huang X; You L; Zhou Z; Jin J
Cytokine; 2023 Sep; 169():156289. PubMed ID: 37453327
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study.
Cencini E; Sicuranza A; Fabbri A; Marzano C; Pacelli P; Caroni F; Raspadori D; Bocchia M
Leuk Lymphoma; 2023 Oct; 64(10):1634-1642. PubMed ID: 37424258
[TBL] [Abstract] [Full Text] [Related]
14. The genetic polymorphisms of immune-related genes contribute to the susceptibility and survival of lymphoma.
Gu C; Can C; Liu J; Wei Y; Yang X; Guo X; Wang R; Jia W; Liu W; Ma D
Cancer Med; 2023 Jul; 12(14):14960-14978. PubMed ID: 37329186
[TBL] [Abstract] [Full Text] [Related]
15. Cytokine network imbalance in children with B-cell acute lymphoblastic leukemia at diagnosis.
Dai Q; Zhang G; Wang Y; Ye L; Shi R; Peng L; Guo S; He J; Yang H; Zhang Y; Jiang Y
Cytokine; 2023 Sep; 169():156267. PubMed ID: 37320964
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.
Brown AK; Carapellucci J; Oshrine B; Gomez A; Meoded A; Asante-Korang A
Clin Transplant; 2023 Sep; 37(9):e15015. PubMed ID: 37237443
[TBL] [Abstract] [Full Text] [Related]
17. Case report of extranodal natural killer/T-cell lymphoma that induced secondary hemophagocytic syndrome-related histiocytic glomerulopathy.
Xiao F; Hou S; Kui K; Wang X; Bai L; Dai H
J Int Med Res; 2023 May; 51(5):3000605231158952. PubMed ID: 37161317
[TBL] [Abstract] [Full Text] [Related]
18. [Adult T-cell leukemia/lymphoma with multiple intracranial masses and CMV and HHV-6 reactivation at initial presentation].
Hori T; Yasui S; Hosoki M; Yamagami H; Otoda T; Yuasa T; Aihara KI; Takishita M; Abe M; Nakamura S
Rinsho Ketsueki; 2023; 64(4):283-289. PubMed ID: 37121773
[TBL] [Abstract] [Full Text] [Related]
19. The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH.
Chu Y; Zhang M; Cui Y; Xie D; Wang M; Yang L; Wang S; Wang J
World J Urol; 2023 May; 41(5):1395-1400. PubMed ID: 37103567
[TBL] [Abstract] [Full Text] [Related]
20. External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center.
Li A; De Las Pozas G; Andersen CR; Nze CC; Toale KM; Milner EM; Fillmore NR; Chiao EY; Rojas Hernandez C; Kroll MH; Merriman KW; Flowers CR
Am J Hematol; 2023 Jul; 98(7):1052-1057. PubMed ID: 37067102
[TBL] [Abstract] [Full Text] [Related]
[Next]
